Your browser doesn't support javascript.
loading
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study.
Visentin, Andrea; Mauro, Francesca Romana; Cibien, Francesca; Vitale, Candida; Reda, Gianluigi; Fresa, Alberto; Ciolli, Stefania; Pietrasanta, Daniela; Marchetti, Monia; Murru, Roberta; Gentile, Massimo; Rigolin, Gian Matteo; Quaglia, Francesca Maria; Scarfò, Lydia; Sportoletti, Paolo; Pravato, Stefano; Piazza, Francesco; Coscia, Marta; Laurenti, Luca; Molica, Stefano; Foà, Robin; Cuneo, Antonio; Trentin, Livio.
  • Visentin A; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padova, Italy.
  • Mauro FR; Venetian Institute of Molecular Medicine, Padua, Italy.
  • Cibien F; Hematology, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy.
  • Vitale C; Hematology Unit, Ca' Foncello Hospital, Treviso, Italy.
  • Reda G; Department of Molecular Biotechnology and Health Sciences, University of Torino and Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
  • Fresa A; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore, University of Milan, Milan, Italy.
  • Ciolli S; Hematology Institute, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy.
  • Pietrasanta D; Hematology Unit, Careggi Hospital, University of Florence, Florence, Italy.
  • Marchetti M; Division of Hematology, A.O. SS Antonio e Biagio and Cesare Arrigo, Alessandria, Italy.
  • Murru R; Division of Hematology, A.O. SS Antonio e Biagio and Cesare Arrigo, Alessandria, Italy.
  • Gentile M; Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS "G. Brotzu", Cagliari, Italy.
  • Rigolin GM; Hematology Unit, Department of Hemato-Oncology, Annunziata Hospital, Cosenza, Italy.
  • Quaglia FM; Hematology Section, Department of Medical Sciences, Azienda Ospedaliera-Universitaria, Arcispedale S. Anna, University of Ferrara, Ferrara, Italy.
  • Scarfò L; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Sportoletti P; Strategic Research Program on CLL, Vita-Salute University and IRCSS San Raffaele Hospital, Milan, Italy.
  • Pravato S; Hematology and Clinical Immunology Unit, University of Perugia, Perugia, Italy.
  • Piazza F; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padova, Italy.
  • Coscia M; Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padova, Italy.
  • Laurenti L; Venetian Institute of Molecular Medicine, Padua, Italy.
  • Molica S; Department of Molecular Biotechnology and Health Sciences, University of Torino and Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy.
  • Foà R; Hematology Institute, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy.
  • Cuneo A; Department Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.
  • Trentin L; Hematology, Department of Translational and Precision Medicine, "Sapienza" University, Rome, Italy.
Am J Hematol ; 97(3): E95-E99, 2022 03 01.
Article en En | MEDLINE | ID: mdl-34904743
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crónica de Células B / Proteína p53 Supresora de Tumor / Eliminación de Gen Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crónica de Células B / Proteína p53 Supresora de Tumor / Eliminación de Gen Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article